Novartis reported $4.69B in Trade Creditors for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Trade Creditors Change
Alcon AG ALC:SW USD 854M 76M
Amgen AMGN:US USD 1.2B 52M
Bayer BAYN:GR EUR 6.55B 452M
Biogen BIIB:US USD 383.2M 51.6M
Bristol Myers Squibb BMY:US USD 2.6B 287M
Eli Lilly And LLY:US USD 1.68B 23.9M
Fresenius FRE:GR EUR 1.93B 3M
Galapagos GLPG:NA EUR 154.74M 6M
Hikma Pharmaceutical HIK:LN USD 255M 7M
Merck MRK:GR EUR 2.45B 11M
Novartis NOVN:VX USD 4.69B 276M
Novartis NVS:US USD 4.69B 276M
Orion ORNBV:FH EUR 84.9M 10.8M
Recordati REC:IM EUR 219.64M 2.9M
Regeneron Pharmaceuticals REGN:US USD 535.6M 1.4M